Abstract: Herein, we report ac onvenient and broadly applicable strategy for the difluoromethylation of aryl bromides by metallaphotoredoxc atalysis.B romodifluoromethane,asimple and commercially available alkyl halide,i s harnessed as an effective source of difluoromethyl radical by silyl-radical-mediated halogen abstraction. The merger of this fluoroalkyl electrophile activation pathwaywith adual nickel/ photoredox catalytic platform enables the difluoromethylation of adiverse array of aryl and heteroaryl bromides under mild conditions.T he utility of this procedure is showcased in the late-stage functionalization of several drug analogues.
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Within the realm of drug design, the chemoselective incorporation of fluorine or polyfluorinated alkyl substituents is apowerful and widely employed tactic to enhance binding selectivity,e levate lipophilicity,a nd/or circumvent metabolism issues arising from in vivo CÀHbond oxidation. [1, 2] While the implementation of the trifluoromethyl group (-CF 3 )h as been widely studied in medicinal chemistry,t he relatively underexplored difluoromethyl group (-CF 2 H) has recently garnered significant attention by virtue of its capacity to serve as alipophilic hydrogen bond donor and to act as abioisostere for thiol and alcohol functional groups. [3, 4] Modern approaches to the direct and selective introduction of the difluoromethyl group into aromatic rings typically rely on the metal-catalyzed cross-coupling of aryl electrophiles or nucleophiles with an appropriate CF 2 HR reagent, often designed for facile transmetalation or formal oxidative addition by the metal catalyst. [5, 6] Given the pronounced practical significance of this emerging area, one of the greatest challenges is the rendering of readily available CF 2 Hs ources as effective difluoromethylating agents in cross-coupling.C rucially,t his coupling platform must display high functional tolerance and amenability towards medicinally relevant scaffolds.A ss uch, the development of novel, operationally convenient, yet general routes to difluoromethylarenes and -heteroarenes remains of high interest.
Metallaphotoredox catalysis has emerged in recent years as avaluable platform for the production of previously elusive C(sp 3 ) À C(sp 2 )b onds,t hereby providing access to novel constructs of importance in medicinal chemistry. [7] One example from our laboratory involves ad ual nickel/photoredox-catalyzed cross-electrophile coupling procedure, wherein the union of ab road range of aryl and alkyl halides is accomplished at room temperature using visible-light irradiation. [8] Au nique design feature of this mechanism is the implementation of silyl-radical-mediated abstraction of bromine atoms from C(sp 3 ) À Br bonds, [9] ap athway that allows alkyl halides to readily participate in metal-catalyzed cross-couplings.M ost notably,t he scope of these silane- Figure 1 . Silane-mediated difluoromethylation of aryl bromides. [10] [*] V. Bacauanu, [ mediated cross-electrophile couplings has been determined to be extensive with respect to both arene substitution pattern and functional group tolerance,acharacteristic that has led to widescale adoption by medicinal chemistry groups within the pharmaceutical sector (Figure 1 ). [11] Inspired by the success of this silyl-radical-mediated crosselectrophile coupling,w ew ondered if an analogous strategy could serve as the basis for ag eneral and direct synthesis of difluoromethylarenes.S pecifically,w ec onsidered bromodifluoromethane,asimple and commercial alkyl halide,a s ap otential source of CF 2 Hr adical through ap reviously unexplored halogen abstraction step.C rucially,t his pathway would be thermodynamically feasible given that the HF 2 CÀBr bond (bond dissociation energy of 69 kcal mol À1 )isfar weaker than the Si À Br bond in at ypical abstraction product (e.g., 96 kcal mol À1 for Me 3 Si À Br). [12] Moreover,given the electronrich character of the silyl radical, we surmised that halogen abstraction from bromodifluoromethane would be polaritymatched and hence kinetically faster than from previously utilized alkyl bromide substrates. [13] Herein, we disclose the successful implementation of these ideals and present amild, convenient, and broadly applicable metallaphotoredox-catalyzed difluoromethylation of aw ide array of aryl and heteroaryl halides.
Thep roposed mechanism for this silane-mediated difluoromethylation is shown in Scheme 1. Visible-light excitation of Ir III photocatalyst [Ir(dF(CF 3 )ppy) 2 (dtbbpy)]PF 6 (1) [14] is known to generate the excited-state *Ir III complex 2, which can readily oxidize bromide anion (3) [8, 15] The resulting bromine radical (5)c an participate in hydrogen atom transfer with (TMS) 3 SiH to yield the nucleophilic silyl radical 6.
[13] Bromine abstraction from bromodifluoromethane (7)b yo pen-shell silyl species 6 would then afford the key difluoromethyl radical (8) . Concurrently with the photoredox catalytic cycle,N i 0 catalyst 9 [16] [a]
[a] Performed with photocatalyst 1 (1 mol %), NiBr 2 ·dtbbpy (5 mol %), aryl bromide (0.2 mmol), CF 2 HBr (1-4 equiv), (TMS) 3 SiH (1.05 equiv), and 2,6-lutidine (2 equiv) in DME for 18 h. Yields determined by 19 FNMR analysis. [b] See the SupportingInformation for experimental details.
We began our investigation by examining three separate aryl halide precursors in the proposed difluoromethylation procedure,n amely cyanopyridine 16 as well as trifluoromethyl-and fluoro-substituted bromobenzenes (17 and 18, respectively;s ee Table 1 ). Fore ach substrate,w ee mployed photocatalyst 1,n ickel catalyst NiBr 2 ·dtbbpy (15), commercially available (TMS) 3 SiH, 2,6-lutidine as the base,DME as the solvent, and blue LEDs as the photon source.Inthe case of electron-deficient heteroaryl bromide 16,optimal levels of reaction efficiency were observed using excess CF 2 HBr (4 equiv,7 7% yield). Remarkably,h owever,w ith the less electron-deficient CF 3 -arene 17,t he use of 2equivalents of bromodifluoromethane gave as uperior outcome,w hile electron-neutral para-fluoro substrate 18 achieved the highest yield with a1:1 stoichiometry of arene to CF 2 HBr. [17] Perhaps more surprising,t he use of al arge excess of bromodifluoro- Table 2 : Scope of the silyl-radical-mediated difluoromethylation of aryl halide electrophiles using bromodifluoromethane as the CF 2 Hs ource.
[a]
[a] Yields of isolated products unless otherwise indicated. Performed with photocatalyst 1 (1 mol %), NiBr 2 ·dtbbpy (5 mol %), aryl bromide (0.5 mmol), CF 2 HBr (1-2 equiv), (TMS) 3 SiH (1.05 equiv),and 2,6-lutidine (2 equiv) in DME for 18 h. See the SupportingInformation for experimental details and additionalexamples. [b] Yield determined by 19 FNMR analysis (average of two runs). 
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Communications methane (4 equiv) led to dramatically diminished yields in the latter two cases. [18, 19] To rationalize these trends,w ep ropose that when less electron-deficient arenes are employed, the catalytic nickel species can undergo oxidative addition with the electrondeficient CF 2 HBr reagent at ar ate competitive with the aryl bromide insertion step. [20] Moreover,w eb elieve that such ap athway would be deleterious given that the resultant Ni II À CF 2 Hc omplex would be unlikely to participate in further oxidative addition steps with the aryl bromide. [21] As such, for more electron-rich or hindered aryl halides that undergo relatively slow oxidative addition with nickel, the issue of competitive CF 2 HBr insertion is mitigated by employing lower concentrations of the CF 2 Hs ource.H owever,a tt he other end of the electronic spectrum, higher stoichiometry of CF 2 HBr ensures that the silane-mediated generation of the CF 2 Hr adical occurs in synchronicity with the rapid oxidative addition of the nickel catalyst into highly electron-deficient arenes (e.g., 16). [22] With optimized conditions in hand, we next evaluated the scope with respect to the aryl bromide component (Table 2) . Notably,s ubstrates bearing electron-withdrawing groups, such as esters,k etones,n itriles,o rs ulfones,g enerated the respective difluoromethyl adducts in high yields (19-22,7 5-83 %yield). In accord with our optimization studies,electronneutral and electron-rich bromoarenes performed well using lower loadings of CF 2 HBr (23-26,55-80 %yield). As auseful demonstration of the mild conditions and functional group tolerance of this new coupling procedure,wefound that aryl electrophiles bearing chloride and boronate ester groups can be readily implemented (27 and 28,8 0% and 85 %y ield, respectively). This characteristic was further underscored by the performance of substrates containing alcohol and silylalkyne moieties (29 and 30,71% and 75 %yield, respectively) . In addition, meta-a nd ortho-substituted aryl bromides were shown to be competent electrophiles in this transformation (31-34,60-78 %y ield).
We next turned our attention to the scope of heteroaryl halides,acritical group of substrates with respect to the utility of this procedure in the medicinal chemistry sector.Asshown in Table 2 , abroad range of 2-, 3-, and 4-bromopyridines were found to be suitable coupling partners (37-42,46-84 %yield). Moreover,b romoquinolines afforded the desired products with good efficiency( 43 and 44,7 6% and 78 %y ield, respectively). Multiple-nitrogen-bearing heteroarenes,s uch as pyrimidines,p yrazines,a nd quinoxalines,h ave long been viewed as problematic substrates for arange of cross-coupling reactions.Assuch, it was notable that all of these heteroarene classes were readily converted into the corresponding difluoromethylarenes (45-48,6 0-66 %y ield). In the same context, five-membered bromoarenes were also found to be competent electrophiles.I np articular,d ifluoromethyl derivatives of pyrazole,indazole,benzimidazole,and caffeine were obtained in good to high yields (49-52,5 1-75 %y ield). Perhaps most notable,bromothiazoles,atraditionally difficult substrate class for cross-coupling, [23] were readily transformed into their corresponding CF 2 Ha dducts (53 and 54,5 7% and 45 %y ield, respectively).
Finally,g iven the pharmaceutical relevance of the CF 2 H group,w es ought to showcase the utility of our procedure in the late-stage difluoromethylation of analogues of several known medicinal agents (Scheme 2). Specifically,d ifluoromethyl-containing derivatives of sulfadimethoxine,celecoxib, indometacin, and pomalidomide were obtained in good to high yields from the corresponding aryl bromide precursors (55-58,6 4-82 %y ield). These results further highlight the Scheme 2. Late-stagef unctionalization for the expedients ynthesis of difluoromethyl analogues of pharmaceutical agents.
Communications real-world utility of this metallaphotoredox technology with respect to the tolerance of medicinally relevant functional groups,s uch as sulfonamides,i mides,e lectron-rich pyrimidines,pyrazoles,and indoles.
In conclusion, we have developed an ovel metallaphotoredox platform for the difluoromethylation of ab road range of aryl and heteroaryl halides.T his procedure employs commercially available bromodifluoromethane as ad irect source of CF 2 Hr adical via as ilyl radical-mediated halogen abstraction pathway previously unexplored for fluoroalkyl electrophiles within the realm of cross-coupling.G iven its distinct convenience and broad applicability to pharmaceutically relevant scaffolds,w ee xpect this method to be widely adopted within the synthetic and medicinal chemistry community.
